Deepens partnership with COPD Foundation to drive patient awareness and engagement Building on nine decades of 'Caring for Life' globally and ten years of impact in the U.S., Cipla continues to ...
Pharmaceutical major Cipla is focusing on obesity and advanced diabetes care to maintain steady growth, as the revenue contribution from its key U.S. generic cancer drug, Revlimid, begins to slow. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback